Embecta Corp (EMBC) support and resistance · P/E 12, rev $1.08B
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
This page maps Embecta Corp (EMBC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
EMBC currently screens at market cap $609.6M and trailing P/E 11.7. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new EMBC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the EMBC quote page for the session range and the stock page for the full model.
Not investment advice.